These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 12543057)

  • 1. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE
    Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of St John's wort in depression : what is known?
    Butterweck V
    CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hyperforin in the pharmacological activities of St. John's Wort.
    Zanoli P
    CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX; Venkatanarayanan N; Ho CY
    J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of action of St. Johns wort extract].
    Müller WE; Singer A; Wonnemann M
    Praxis (Bern 1994); 2000 Dec; 89(50):2111-21. PubMed ID: 11155494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways.
    Wonnemann M; Singer A; Müller WE
    Neuropsychopharmacology; 2000 Aug; 23(2):188-97. PubMed ID: 10882845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Phillipson JD
    J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. St John's wort: Prozac from the plant kingdom.
    Di Carlo G; Borrelli F; Ernst E; Izzo AA
    Trends Pharmacol Sci; 2001 Jun; 22(6):292-7. PubMed ID: 11395157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
    Klier CM; Schmid-Siegel B; Schäfer MR; Lenz G; Saria A; Lee A; Zernig G
    J Clin Psychiatry; 2006 Feb; 67(2):305-9. PubMed ID: 16566628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
    Gelenberg AJ; Shelton RC; Crits-Christoph P; Keller MB; Dunner DL; Hirschfeld RM; Thase ME; Russell JM; Lydiard RB; Gallop RJ; Todd L; Hellerstein DJ; Goodnick PJ; Keitner GI; Stahl SM; Halbreich U; Hopkins HS
    J Clin Psychiatry; 2004 Aug; 65(8):1114-9. PubMed ID: 15323598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. About the cover: St. John's wort.
    J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
    Röder C; Schaefer M; Leucht S
    Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.
    Wonnemann M; Singer A; Siebert B; Müller WE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S148-51. PubMed ID: 11518066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G; Schüle C; Baghai T; Kieser M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperforin--antidepressant activity by a novel mechanism of action.
    Müller WE; Singer A; Wonnemann M
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S98-102. PubMed ID: 11518085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. St. John's wort: role of active compounds for its mechanism of action and efficacy.
    Butterweck V; Schmidt M
    Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.